The paradoxical effects of interleukin 10 in the immunoregulation of autoimmune diabetes

被引:50
|
作者
Balasa, B [1 ]
Sarvetnick, N [1 ]
机构
[1] Scripps Res Inst, DEPT NEUROPHARMACOL, LA JOLLA, CA 92037 USA
关键词
IDDM; IL-10; NOD; transgenic; T helper;
D O I
10.1006/jaut.1996.0036
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Insulin-dependent diabetes mellitus (IDDM) is a chronic autoimmune disease and spontaneously develops in NOD mice and humans. The role of T helper 1 (Th1) and T helper 2 (Th2) cytokines in the immunopathogenesis of disease is not understood. IL-10 has presented a particularly paradoxical role. Transgenic (Tg) BALB/c mice expressing IL-10 in the pancreas exhibited periinsulitis but not insulitis and diabetes. However, backcrossing of these Tg mice with NOD mice accelerated the onset of diabetes, indicating a pathogenic role for IL-IO in the pathogenesis of autoimmune diabetes since it is able to replace the genetic susceptibility information on the NOD genome. Conversely, administration of IL-10 to adult NOD delayed the onset of and decreased the incidence of diabetes suggesting a potential therapeutic role for IL-10 in autoimmune diabetes. Overall, the findings indicated a paradoxical role for IL-10 in the immunoregulation of autoimmune diabetes. (C) 1996 Academic Press Limited
引用
收藏
页码:283 / 286
页数:4
相关论文
共 50 条
  • [31] Protection from autoimmune diabetes by adjuvant therapy in the non-obese diabetic mouse: The role of interleukin-4 and interleukin-10
    Calcinaro, F
    Gambelunghe, G
    Lafferty, KJ
    IMMUNOLOGY AND CELL BIOLOGY, 1997, 75 (05): : 467 - 471
  • [32] Adaptive immunoregulation of luteolin and chlorogenic acid in lipopolysaccharide-induced interleukin-10 expression
    Cheng, Chu-Yen
    Yeh, Chia-Chou
    TZU CHI MEDICAL JOURNAL, 2020, 32 (02): : 186 - 192
  • [33] AUTOIMMUNE DIABETES AS A CONSEQUENCE OF LOCALLY PRODUCED INTERLEUKIN-2
    HEATH, WR
    ALLISON, J
    HOFFMANN, MW
    SCHONRICH, G
    HAMMERLING, G
    ARNOLD, B
    MILLER, JFAP
    NATURE, 1992, 359 (6395) : 547 - 549
  • [34] Interleukin-13 prevents autoimmune diabetes in NOD mice
    Zaccone, P
    Phillips, J
    Conget, I
    Gomis, R
    Haskins, K
    Minty, A
    Bendtzen, K
    Cooke, A
    Nicoletti, F
    DIABETES, 1999, 48 (08) : 1522 - 1528
  • [35] EFFECT OF INTERLEUKIN-2 ON AUTOIMMUNE DIABETES IN BB RATS
    BURKART, V
    ZIELASEK, J
    KIESEL, U
    KOLB, H
    IMMUNOBIOLOGY, 1986, 173 (2-5) : 326 - 326
  • [36] IMMUNOREGULATION OF AUTOIMMUNE DISORDERS - THE ROLE OF INTRAVENOUS IMMUNOGLOBULINS
    LUZI, G
    FERRARA, R
    INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 1993, 16 : 189 - 195
  • [37] Antibody therapeutics and immunoregulation in cancer and autoimmune disease
    Yasunaga, Masahiro
    SEMINARS IN CANCER BIOLOGY, 2020, 64 : 1 - 12
  • [39] Transgenic interleukin 10 prevents induction of experimental autoimmune encephalomyelitis
    Cua, DJ
    Groux, H
    Hinton, DR
    Stohlman, SA
    Coffman, RL
    JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 189 (06): : 1005 - 1010
  • [40] The Roles of Exosomes in Immunoregulation and Autoimmune Thyroid Diseases
    Zou, Junli
    Peng, Huiyong
    Liu, Yingzhao
    FRONTIERS IN IMMUNOLOGY, 2021, 12